Q: Outlook for this name?
5i Research Answer:
DR had a very good year in 2024. We would not expect the same type of returns going forward. It is a decent company, but growth is expected to slow and lower earnings are expected this year. The dividend has grown recently, but has also been cut in the past (2019). The stock is cheap, but with the US likely to pressure costs it may stay on the cheap side for a period of time. Decent, but not exciting here, especially with an expected lower EPS.